CDC NVEST JURIKA & VOYLES SMALL CAP GROWTH FUND
                         CDC NVEST LARGE CAP VALUE FUND
                         CDC NVEST SHORT TERM BOND FUND

Supplement dated March 13, 2003 to the CDC Nvest Equity Funds Classes A, B and C
and Class Y  Prospectuses,  each dated May 1, 2002 as revised July 1, 2002;  the
CDC Nvest Income Funds Classes A, B and C and Class Y  Prospectuses,  each dated
May 1,  2002;  CDC Nvest  Equity  Funds SAI Part I dated May 1, 2002 as  revised
November 1, 2002; CDC Nvest Income Funds SAI Part I and CDC Nvest Funds SAI Part
II, each dated May 1, 2002, each as may be supplemented from time to time

Effective  March 24, 2003, CDC IXIS Asset  Management  Distributors,  L.P. ("CDC
IXIS  Distributors"),  the  distributor  for CDC Nvest Jurika & Voyles Small Cap
Growth  Fund,  CDC Nvest Large Cap Value Fund and CDC Nvest Short Term Bond Fund
(the "Funds"),  will no longer accept new  investments  in the Funds.  Effective
April  30,  2003,  CDC  IXIS  Distributors  will  no  longer  accept  additional
investments  from current  shareholders  of the Funds which  include  additional
investments  through  automatic or systematic  investment plans. The liquidation
process will involve effecting portfolio  transactions in an orderly manner with
the intent that shareholders remaining in the Funds on the liquidation date will
not  unnecessarily  bear the majority of the trading costs  associated  with the
liquidation.  This may result in the Funds' portfolios  consisting  primarily of
cash or cash equivalents for several weeks prior to the liquidation date.

On February 28, 2003,  the Board of Trustees of CDC Nvest Funds Trust II and CDC
Nvest  Funds  Trust  III,  upon the  recommendation  of CDC  IXIS  Distributors,
approved  separate plans to liquidate each of the Funds,  such  liquidations  to
take place on or about May 16, 2003 (the "Liquidation  Date"). Any shares of the
Funds outstanding on the Liquidation Date will be automatically redeemed on that
date.  The proceeds of any such  redemption  will be the net asset value of such
shares  after  charges,   dividend   distributions  required  to  eliminate  any
Fund-level  taxes,  expenses  and  liabilities  of the  Funds  have been paid or
otherwise  provided for. Any  applicable  sales  charges,  including  contingent
deferred sales charges, will be waived for any shares that remain invested until
the Liquidation Date. For federal income tax purposes,  the automatic redemption
on the Liquidation  Date will generally be treated like any other  redemption of
shares and may result in a gain or loss for  federal  income tax  purposes.  Any
gain will result in short- or long-term  capital gains for shareholders who hold
their shares as a capital asset depending on how long a shareholder has held his
or her Fund shares.  If a  shareholder  desires to recognize any taxable gain or
loss prior to the  Liquidation  Date, the  shareholder may wish to redeem his or
her shares  prior to the  Liquidation  Date.  Before  doing so, the  shareholder
should  consider any applicable  sales charge and should consult with his or her
tax advisor for more information on his or her own situation.

At any time prior to the Liquidation Date,  shareholders may redeem their shares
of the Funds pursuant to the  procedures set forth under "Fund  Services" in the
Funds' Prospectuses. Such redemptions, unlike the automatic redemptions upon the
Liquidation  Date,  will be subject to any applicable  sales charges,  including
contingent  deferred  sales  charges.  The check  writing  privilege for Class A
shares of CDC Nvest Short Term Bond Fund will  terminate on April 30, 2003.  CDC
Nvest Funds will not accept any checks written on CDC Nvest Short Term Bond Fund
accounts  which are received  after April 30, 2003.  CDC Nvest Funds will not be
responsible  for any charges or fees incurred by shareholders as a result of the
failure  to accept  these  checks.  All other  redemption  options  will  remain
available until the date of liquidation.

Shareholders  may also exchange their shares for shares of the same class of any
other CDC Nvest Fund that offers that class, as described under "Fund Services -
Exchanging Shares" in the Funds' Prospectuses.  Such an exchange will not result
in any sales charge. For federal income tax purposes, an exchange of Fund shares
for shares of another CDC Nvest Fund is  generally  treated as a sale on which a
gain or loss may be recognized. A shareholder should consult with his or her tax
adviser for more information on his or her own situation.

Absent an instruction to the contrary  prior to the  Liquidation  Date, for Fund
shares  held in  individual  retirement  accounts  ("IRAs") or SIMPLE  IRAs,  in
custodial  accounts  under a SEP,  SARSEP,  or 403(b) plan,  or in certain other
retirement accounts, CDC IXIS Distributors will exchange any shares remaining in
the Fund on the Liquidation  Date into the CDC Nvest Cash Management Trust Money
Market Series.

                                                                      SP180-0303